2. INTRODUCTION
• PID is a major co-morbidity in young sexually active
women
• The prevalence of PID increased worldwide
• Usually results from sexually transmitted pathogens
ascending from the lower to upper genital tract
• PID is important as it can have long term sequela
6. WHO GETS PID?...
• Young age (<25)
• Multiple sexual partners
• Past history of STI
• Termination of pregnancy
• Procedure- Hysterosalpingography (HSG), IVF
• Smoker
7. SYMPTOMS….
• Can be symptomatic or asymptomatic
• Lower abdominal pain which is typically bilateral
• Fever (> 38 degree)
• Deep dyspareunia
• Chronic pelvic pain
• Abnormal vaginal bleeding- post-coital bleed, inter-menstrual
bleed, menorrhagia
• Abnormal vaginal or cervical discharge- which is often
purulent
8. SIGNS
• Fever
• Lower abdominal tenderness
• Cervical motion tenderness on bimanual examination
• Abnormal vaginal or cervical discharge- which is often
purulent
Gonorrhea Chlamydia
*Clinical signs & symptoms lack sensitivity & specificity
10. DIAGNOSIS….
• The investigations available to diagnose PID are lack of
sensitivity
1. Blood tests
- Raised WCC (neutrophilia suggestive of acute inflammatory
process)
- Reduced WCC (neutropenia in severe infection)
- Raised CRP and ESR
11. 2. Microbiological tests…
NEISSERIA GONORRHEA CHLAMYDIA TRACHOMATIS
1.Endocervical swab
-should be placed in transport medium
-must reached lab within 6H but less
than 24H otherwise viability will be lost
1.Endocervical swab for chlamydia
NAAT (nucleic acid amplification test)
-More sensitive than culture
-Can be used as diagnostic / screening
test on non invasively collected
specimens (urine and vaginal swabs)
12. What SGH Lab has to offer for
Gonorrhea?
• SGH lab does not have NAATs yet.
• Current investigation that our lab has is Culture
• As long as the technique of sample collection is accurate,
Culture offers a high sensitivity of getting a diagnosis.
13. What SGH Lab has to offer for
Chlamydia?
• Immunofluorescence
• A special collection kit is available in SGH Lab
• Proper smear and fixing of sample is require in order to
run the investigation.
• During office hour, lab technician can help us do the test
14. 3.Radiology investigations
ULTRASOUND
-may also be helpful
-insufficent evidence to support
their routine use
-present of adnexa mass,
hydrosalpinx or fluid collection in
POD
LAPAROSCOPY
-may strongly support the dx
-not routinely done due to cost &
invasive
-The Fitz Hugh Curtis syndrome
adhesion between liver and
peritoneal surface (typical violin
string appearance)
15. SCREENING FOR STIs…
1.Women who tested positive for gonorrhea and chlamydia
2.Women at higher risk of STIs – multiple sexual partner
3.Previous history of STI
HIV
VDRL
HEPATITIS B/C
# REMEMBER to screen husband or partner
16. AIMS of management….
1.Start treatment as early as possible to prevent long term
sequelae
Long term sequelae
Ectopic pregnancy
Infertility
Chronic pelvic pain
2.To investigate and treat sexual partner in order to prevent
re-infection
17. General measures..
• Rest is advised for those with severe disease
• UPT test should be performed
• Appropriate analgesia
• Avoid unprotected intercourse until completed treatment
• Contact tracing
18. TREATMENT…
• Low threshold for empirical treatment of PID is
recommended depends on severity
• Broad spectrum antibiotic is required to cover
1.Neisseria Gonorrhea
2.Chlamydia trachomatis
3.Aerobic & anaerobic bacteria
• Outpatient – as effective as inpatient treatment with
clinically mild to moderate PID
19. Antibiotic regimes
• OUTPATIENT REGIMES..
1.IM ceftriaxone 500mg stat
-followed by T.Doxycycline 100mg bd and T.Metronidazole
400mg bd for 2 weeks
Or
2.T.Ofloxacin 400mg bd and T.Metronidazole 400mg bd for
2 weeks
20. • ALTERNATIVE REGIMES
1.IM Ceftriaxone 500mg stat
-followed by T.Azithromycin 1g/week for 2 weeks
(# evidence is limited but may be used if previous treatment
are not appropiate eg allergy/ intolerance)
Or
2.T.Moxifloxacin 400mg od for 2 weeks
21. • INPATIENT REGIMES
• Severe infection
• Adnexal mass suspicious of abscess
• Generalized sepsis
• Poor/ inadequate response to oral treatment
• Severe pelvic/ abdominal pain requiring strong analgesics
• Intravenous therapy should be continued until 24hours
after clinical improvement and followed by oral therapy
22. • REGIMES..
1.IV Ceftriaxone 2g od & IV Doxycycline followed by
T.Doxycycline 100 mg od & T.Metronidazole 400mg bd for 2
weeks
Or
2.IV Clindamycin 900mg tds & IV Gentamicin (2mg/kg loading
dose) then 1.5mg/kg tds followed by
T.Clindamycin 450mg qid or
T.Doxycycline 100mg bd & T.Metronidazole 400mg nd for 2
weeks
23. • ALTERNATIVE REGIMES
1.IV Ofloxacin 400mg bd & IV Metronidazole 500mg tds for
2 weeks
Or
2.IV Ciprofloxacin 200mg & IV Doxycycline 100mg bd & IV
Metronidazole 500mg tds for 2 weeks
24. SURGICAL TREATMENT..
• Should be considered in following situations
-a surgical emergency cannot be excluded
-lack of response to oral therapy
-clinically severe disease
-presence of a tubo-ovarian abscess
-intolerance to oral therapy
-pregnancy
25. • LAPAROSCOPY
-dividing adhessions and draining pelvic abscess
• LAPAROTOMY
-digital divission of all adhessions and any loculated area of
abscess formation
• ULTRASOUND GUIDED ASPIRATION
-less invasive
-can be done if small abscess or collection at POD
26. TREAT PARTNER…
• Current male partner of women with PID should be
contacted
• Offered health advice
• Screening for gonorrhea and chlamydia
• TX: IM Ceftriaxone 500mg stat
#Advice avoid SI until completed treatment
27. FOLLOW UP…
• Review in 2-4 weeks to ensure
-adequate clinical response to treatment
-compliance with oral antibiotics
-screening and treatment of sexual contacts
-awareness of long term sequale of PID
-repeat UPT if indicated
• Repeat testing for gonorrhea and chlamydia after 2-4
weeks in those with persistent symptoms
29. 1.PREVENTION
• Monogamous relationship
• Early onset of sexual intercourse
• Avoidance of high risk behaviour
30. • Health education & Sex education
• Our DILEMMA !!
-Sex education should not be discussed in school
-Limited or no access for education & information on
reproductive sexual health care
-Policies often restrict adolescent’s access to information &
services (eg contraception)
31. • NATIONAL STRATEGIES
1.School based health, life, sex & relationship education
2.Campaigns & media
3.Availability of contraception
• Co-ordination- national, state, district
32. • Barrier methods
-consistent use of barrier methods has been shown to
reduce the risk of recurrent episodes of pelvic infection &
long term sequela by 30-60%
33. • There is significant risk of introducing infection into the
upper genital tract when instrumenting the uterus
• Ensure sterility during procedure (ERPOC, HSG, IVF)
• Avoid illegal termination
34. 2.SCREENING
• UNIVERSAL VS SELECTIVE
• To screen all women or high risk women?
• Cost effective or not?
VS
35. 3.CONTACT TRACING
• Tracing contact within a 6 month period of onset of
symptoms is recommended
• Must get proper sexual history from the patient
• Patient’s co-operation !!
36. 4.NOTIFICATIONS
• Notification system those with STIs or PID?
• Where and how to notify?
• Does it break patient’s confidentiality?
